—
Saturday, September 16, 2023
Autologous stem cell transplant (ASCT) remains an important option for eligible multiple myeloma (MM) pat...
Read more
—
Friday, September 15, 2023
We are pleased to let you know that as of September 1st, selinexor – under the following conditions – is...
Read more
—
Friday, September 15, 2023
B cell maturation antigen (BCMA) target loss is considered to be a rare event that mediates multiple myel...
Read more
—
Wednesday, August 23, 2023
On the recommendation of Dean Jane Philpott, Teri Shearer, Interim Provost and Vice-Principal (Academic)...
Read more
—
Tuesday, August 22, 2023
New vaccine formulations targeting currently circulating strains are expected. The country's national vac...
Read more
—
Monday, August 21, 2023
Through Bill C-224, starting next year, the month of January will be declared “Firefighter Cancer Awarene...
Read more